Roberto Giacomelli

Roberto Giacomelli publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Roberto Giacomelli sits on this spectrum.

Roberto Giacomelli D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Roberto Giacomelli sits on this spectrum.

Overview

Best Publications

• Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

  Angelo Agostoni;Emel Aygören-Pürsün;Karen E. Binkley;Alvaro Blanch

  876
  Citations

• A comprehensive review on adult onset Still's disease.

  Roberto Giacomelli;Piero Ruscitti;Yehuda Shoenfeld

  428
  Citations

• European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes

  G. Valentini;A. Della Rossa;S. Bombardieri;W. Bencivelli

  424
  Citations

• Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

  Oliver Distler;Angela del Rosso;Roberto Giacomelli;Paola Cipriani

  380
  Citations

• Beyond the joints, the extra-articular manifestations in rheumatoid arthritis.

  Alessandro Conforti;Ilenia Di Cola;Viktoriya Pavlych;Piero Ruscitti

  352
  Citations

• Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?

  Francesco Caso;Luisa Costa;Piero Ruscitti;Luca Navarini

  290
  Citations

• Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation?

  Alessandra Marrelli;Paola Cipriani;Vasiliki Liakouli;Francesco Carubbi

  251
  Citations

• The role of IL-1β in the bone loss during rheumatic diseases.

  Piero Ruscitti;Paola Cipriani;Francesco Carubbi;Vasiliki Liakouli

  223
  Citations

• Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.

  Pilar Brito-Zerón;Pilar Brito-Zerón;Nihan Acar-Denizli;Margit Zeher;Astrid Rasmussen

  223
  Citations

• Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry

  Fabiola Atzeni;Piercarlo Sarzi-Puttini;Costantino Botsios;Antonio Carletto

  222
  Citations

• Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

  Francesco Carubbi;Paola Cipriani;Alessandra Marrelli;Paola Di Benedetto

  220
  Citations

• Vascular complications of scleroderma

  Serena Guiducci;Roberto Giacomelli;Marco Matucci Cerinic

  212
  Citations

• Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.

  P. Cipriani;S. Guiducci;I. Miniati;M. Cinelli

  200
  Citations

• Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population‐based multicentre cohort study

  E. Bartoloni;C. Baldini;G. Schillaci;L. Quartuccio

  197
  Citations

• Infliximab in spondyloarthropathy associated with Crohn’s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

  S Generini;R Giacomelli;R Fedi;A Fulminis

  189
  Citations

• Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis

  Roberto Giacomelli;Gabriele Valentini;Felice Salsano;Paola Cipriani

  181
  Citations

• Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.

  Luca Quartuccio;Miriam Isola;Chiara Baldini;Roberta Priori

  178
  Citations

• Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

  Piero Ruscitti;Paola Cipriani;Francesco Masedu;Daniela Iacono

  176
  Citations

• Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren’s syndrome with ectopic germinal centres and MALT lymphoma

  Elena Pontarini;William James Murray-Brown;Cristina Croia;Davide Lucchesi

  173
  Citations

• International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management

  Roberto Giacomelli;Antonella Afeltra;Alessia Alunno;Chiara Baldini

  169
  Citations

• Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis

  G Frieri;R Giacomelli;M Pimpo;G Palumbo

  157
  Citations

• European multicentre study to define disease activity criteria for systemic sclerosis.* I. Clinical and epidemiological features of 290 patients from 19 centres

  A. Della Rossa;G. Valentini;S. Bombardieri;W. Bencivelli

  156
  Citations